- Home
- RGCO vs HRTX Comparison
RGCO vs HRTX Comparison
Compare RGCO & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RGCO | HRTX |
|---|---|---|
| Founded | 1912 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.9M | 203.5M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | RGCO | HRTX |
|---|---|---|
| Price | $22.23 | $1.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 9.6K | ★ 2.2M |
| Earning Date | 11-19-2025 | 11-04-2025 |
| Dividend Yield | ★ 3.77% | N/A |
| EPS Growth | ★ 11.26 | N/A |
| EPS | ★ 1.29 | N/A |
| Revenue | $95,334,212.00 | ★ $155,097,000.00 |
| Revenue This Year | $9.00 | $10.62 |
| Revenue Next Year | $8.30 | $12.99 |
| P/E Ratio | $17.10 | ★ N/A |
| Revenue Growth | ★ 12.63 | 12.60 |
| 52 Week Low | $19.06 | $1.00 |
| 52 Week High | $23.82 | $2.68 |
Technical Indicators
Market Signals| Indicator | RGCO | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.49 | 47.95 |
| Support Level | $21.98 | $1.10 |
| Resistance Level | $22.83 | $1.14 |
| Average True Range (ATR) | 0.64 | 0.07 |
| MACD | 0.13 | 0.01 |
| Stochastic Oscillator | 75.90 | 76.48 |
Price Performance
Historical ComparisonAbout RGCO RGC Resources Inc.
RGC Resources Inc is involved in the business of distribution and sale of natural gas to residential, commercial, and industrial customers within its service territory in Roanoke, Virginia, and its surrounding localities. The company also provides certain non-regulated services. The company relies on multiple interstate pipelines to transport natural gas. The company operates in three segments: Gas Utility, which is the key revenue generator; Investment in Affiliates this segment reflects the income generated through the activities of the Company's investment in MVP and Southgate projects and Parent & Other including the unregulated activities of the Company as well as certain corporate eliminations.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.